United States, Delaware, Wilmington – 03-25-2020 (PRDistribution.com) — 
Wilmington, Delaware – March 25, 2020. CloudLIMS recognizes the threat to global health the COVID-19 pandemic brings. To do our part, we are making our flagship in the cloud LIMS (Laboratory Information Management System), CloudLIMS Enterprise, free of charge to any research facility or diagnostics laboratory doing SARS-CoV-2 or COVID-19 research or testing, be it any part of the world.
Any research facility doing COVID-19 research or diagnostics lab can use the Enterprise edition of CloudLIMS free of charge for a year. The Enterprise edition is the company’s flagship product that includes sample management, test management, inventory control, kits collection, as well as package and shipment modules. The offer also covers all our complimentary services which include our premier technical support, product configuration, hosting, instrument integration, automatic backups, and secure data access. We will do everything we can to get any research or testing lab running as quickly as possible.“CloudLIMS recognizes the urgency in combating the coronavirus pandemic and the need for our testing and research facilities to focus on the problem at hand,” said Arun Apte, Chief Executive Officer at CloudLIMS. “We would like to do our part in this fight against COVID-19 by doing a fast and easy setup for anyone that needs it,” he continued. To make use of the offer, sign up for a free subscription of CloudLIMS Enterprise.About CloudLIMSEstablished in 2013, CloudLIMS is an energetic team of professionals producing cutting edge laboratory software solutions, such as sample management software and LIMS. For more information, please visit: www.cloudlims.com Contact:
Ankita Acharya
CloudLIMS.com
302-789-0447
[email protected]
Media Contacts:
Company Name: CloudLIMS
Full Name: Ankita Acharya
Phone: 3027890447
Email Address: Send Email
Website: www.cloudlims.com
For the original news story, please visit https://prdistribution.com/news/cloudlims-offers-free-lims-globally-to-sars-cov-2-covid-19-research-testing-laboratories.html.